As of May 25
| -0.18 / -1.32%|
The 8 analysts offering 12-month price forecasts for Cross Country Healthcare Inc have a median target of 18.50, with a high estimate of 23.00 and a low estimate of 14.00. The median estimate represents a +37.34% increase from the last price of 13.47.
The current consensus among 9 polled investment analysts is to Buy stock in Cross Country Healthcare Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.